Your browser doesn't support javascript.
loading
A prospective observational study of 915 patients with systemic AL amyloidosis treated with upfront bortezomib.
Manwani, Richa; Cohen, Oliver; Sharpley, Faye; Mahmood, Shameem; Sachchithanantham, Sajitha; Foard, Darren; Lachmann, Helen J; Quarta, Cristina; Fontana, Marianna; Gillmore, Julian D; Whelan, Carol; Hawkins, Philip N; Wechalekar, Ashutosh D.
Afiliación
  • Manwani R; National Amyloidosis Centre, University College London, Royal Free Campus, London, United Kingdom.
  • Cohen O; National Amyloidosis Centre, University College London, Royal Free Campus, London, United Kingdom.
  • Sharpley F; National Amyloidosis Centre, University College London, Royal Free Campus, London, United Kingdom.
  • Mahmood S; National Amyloidosis Centre, University College London, Royal Free Campus, London, United Kingdom.
  • Sachchithanantham S; National Amyloidosis Centre, University College London, Royal Free Campus, London, United Kingdom.
  • Foard D; National Amyloidosis Centre, University College London, Royal Free Campus, London, United Kingdom.
  • Lachmann HJ; National Amyloidosis Centre, University College London, Royal Free Campus, London, United Kingdom.
  • Quarta C; National Amyloidosis Centre, University College London, Royal Free Campus, London, United Kingdom.
  • Fontana M; National Amyloidosis Centre, University College London, Royal Free Campus, London, United Kingdom.
  • Gillmore JD; National Amyloidosis Centre, University College London, Royal Free Campus, London, United Kingdom.
  • Whelan C; National Amyloidosis Centre, University College London, Royal Free Campus, London, United Kingdom.
  • Hawkins PN; National Amyloidosis Centre, University College London, Royal Free Campus, London, United Kingdom.
  • Wechalekar AD; National Amyloidosis Centre, University College London, Royal Free Campus, London, United Kingdom.
Blood ; 134(25): 2271-2280, 2019 12 19.
Article en En | MEDLINE | ID: mdl-31578202

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Bortezomib / Amiloidosis de Cadenas Ligeras de las Inmunoglobulinas Tipo de estudio: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Bortezomib / Amiloidosis de Cadenas Ligeras de las Inmunoglobulinas Tipo de estudio: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Estados Unidos